Bioavailability is typically measured through pharmacokinetic studies, which involve tracking the absorption, distribution, metabolism, and excretion (ADME) of a drug. Techniques such as radioactive labeling and fluorescence microscopy are often used to visualize and quantify drug distribution within tissues.